
Dose Escalation to Upadacitinib 30 mg Necessary Among Some with Atopic Dermatitis
Data presented at the American Academy of Dermatology (AAD) Annual Meeting demonstrate that targeting multiple disease pathways is necessary for attaining high efficacy among those with atopic dermatitis, and the mechanistic rationale supports raising …